Number of Shares
189,493.00
Current Holdings Value*
$6.21 Mil
% of Portfolio
1.24%
Total Estimate Gain
$171,466.97
% of Total Estimate Gain
2.93%

Third Avenue Management's Supernus Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Third Avenue Management held 189,493.00 shares of Supernus Pharmaceuticals Inc(SUPN), totaling $6.21 Mil. This investment constitutes 1.24% of their stock portfolio, and Third Avenue Management now holds 0.34% of the outstanding Supernus Pharmaceuticals Inc(SUPN) stock.

The initial trade took place in 2022Q2. And since then Third Avenue Management has made 6 purchases of SUPN, at an average price of $30.86, for a total of 189,493.00 shares. Based on historical transaction data and SUPN's current price of $31.76, Third Avenue Management's estimated gain on his SUPN holdings is $171,466.97, reflecting a 2.93% gain to date.

Third Avenue Management SUPN ($31.76) Holding Chart

Third Avenue Management SUPN ($31.76) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1